These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10850108)

  • 1. [CBO guideline 'Stroke' (revision) Dutch Institute for Healthcare Improvement].
    Limburg M; Tuut MK
    Ned Tijdschr Geneeskd; 2000 May; 144(22):1058-62. PubMed ID: 10850108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolysis, community hospitals, and primary stroke center.
    Jeng JS
    Acta Neurol Taiwan; 2009 Mar; 18(1):1-2. PubMed ID: 19537567
    [No Abstract]   [Full Text] [Related]  

  • 3. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing the management of acute ischaemic stroke: a review of the utilization of intravenous recombinant tissue plasminogen activator (tPA).
    Eissa A; Krass I; Bajorek BV
    J Clin Pharm Ther; 2012 Dec; 37(6):620-9. PubMed ID: 22708668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's new in stroke prevention and treatment.
    Weimar C; Diener HC
    Expert Rev Neurother; 2006 Feb; 6(2):185-93. PubMed ID: 16466298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant tissue plasminogen activator (rt-PA) utilisation by rural clinicians in acute ischaemic stroke: an audit of current practice and clinical outcomes.
    Williams JM; Navin TJ; Jude MR; Levi CR
    Aust J Rural Health; 2013 Aug; 21(4):203-7. PubMed ID: 24033520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombolytic therapy in patients with acute brain infarction: favorable preliminary results in Maastricht].
    Boiten J; Wilmink JT; Lodder J; Troost J
    Ned Tijdschr Geneeskd; 2000 May; 144(22):1062-9. PubMed ID: 10850109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of acute ischaemic stroke with thrombolysis or thrombectomy in patients receiving anti-thrombotic treatment.
    Diener HC; Foerch C; Riess H; Röther J; Schroth G; Weber R
    Lancet Neurol; 2013 Jul; 12(7):677-88. PubMed ID: 23726849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolysis 2004: the good, the bad, and the ugly.
    Caplan LR
    Rev Neurol Dis; 2004; 1(1):16-26. PubMed ID: 16397447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Calculation of costs of stroke, cost effectiveness of stroke units and secondary prevention in patients after a stroke, as recommended by revised CBO practice guideline 'Stroke'].
    Niessen LW; Dippel DW; Limburg M
    Ned Tijdschr Geneeskd; 2000 Oct; 144(41):1959-64. PubMed ID: 11048560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke therapy clinical guideline. South African Medical Association-- Neurological Association of South Africa Stroke Working Group.
    S Afr Med J; 2000 Mar; 90(3 Pt 2):276-8, 280-9, 292-306. PubMed ID: 10853406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute stroke services in New Zealand.
    Barber PA; Anderson NE; Bennett P; Gommans J
    N Z Med J; 2002 Jan; 115(1146):3-6. PubMed ID: 11936348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paul Coverdell National Acute Stroke Registry Surveillance - four states, 2005-2007.
    George MG; Tong X; McGruder H; Yoon P; Rosamond W; Winquist A; Hinchey J; Wall HK; Pandey DK;
    MMWR Surveill Summ; 2009 Nov; 58(7):1-23. PubMed ID: 19893482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous Thrombolysis and Risk Factors for Ischemic Stroke.
    Shrestha S; Poudel RS; Thapa LJ; Khatiwada D
    JNMA J Nepal Med Assoc; 2014; 52(193):745-50. PubMed ID: 26905561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on intravenous recombinant tissue plasminogen activator for acute ischemic stroke.
    Fugate JE; Rabinstein AA
    Mayo Clin Proc; 2014 Jul; 89(7):960-72. PubMed ID: 24775222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What's the "hyper" in hyperacute stroke? Strategies to improve outcomes in ischemic stroke patients presenting within 6 hours.
    Bader MK; Palmer S
    AACN Adv Crit Care; 2006; 17(2):194-214. PubMed ID: 16767022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombolysis in stroke--results of the ECASS study (European Cooperative Acute Stroke Study)].
    Nervenarzt; 1995 Aug; 66(8 Suppl):1-8. PubMed ID: 9131091
    [No Abstract]   [Full Text] [Related]  

  • 18. 4.5-hour time window for intravenous thrombolysis with recombinant tissue-type plasminogen activator is established firmly.
    Schellinger PD; Köhrmann M
    Stroke; 2014 Mar; 45(3):912-3. PubMed ID: 24526060
    [No Abstract]   [Full Text] [Related]  

  • 19. Intraarterial thrombolysis within the first three hours after acute ischemic stroke in selected patients.
    Moonis M
    Stroke; 2009 Jul; 40(7):2611-2. PubMed ID: 19443796
    [No Abstract]   [Full Text] [Related]  

  • 20. Hospital resources for urokinase/recombinant tissue-type plasminogen activator therapy for acute stroke in Beijing.
    Wang Y; Wu D; Zhao X; Ma R; Guo X; Wang C; Liu L; Zhao W; Wang Y
    Surg Neurol; 2009 Aug; 72 Suppl 1():S2-7. PubMed ID: 18423545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.